Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 16, Pages 3507
Publisher
MDPI AG
Online
2021-08-09
DOI
10.3390/jcm10163507
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study
- (2021) Tak Kyu Oh et al. ACTA DIABETOLOGICA
- Multifaceted Mechanisms of Action of Metformin Which Have Been Unraveled One after Another in the Long History
- (2021) Hideaki Kaneto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes
- (2021) Jingya Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity.
- (2021) Carolyn T. Bramante et al. JOURNAL OF MEDICAL VIROLOGY
- Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis
- (2021) Tahmina Nasrin Poly et al. Frontiers in Medicine
- Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
- (2021) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review
- (2021) Moein Zangiabadian et al. Frontiers in Endocrinology
- Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19
- (2021) Chieh-Chen Wu et al. Journal of Clinical Medicine
- Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses
- (2021) Morvarid Siri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Two-Stage Study Identifies Two Novel Polymorphisms in PRKAG2 Affecting Metformin Response in Chinese Type 2 Diabetes Patients
- (2021) Di Xiao et al. Pharmacogenomics & Personalized Medicine
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Metformin Reduces the Senescence of Renal Tubular Epithelial Cells in Diabetic Nephropathy via the MBNL1/miR-130a-3p/STAT3 Pathway
- (2020) Xue Jiang et al. Oxidative Medicine and Cellular Longevity
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Metformin attenuates adhesion between cancer and endothelial cells in chronic hyperglycemia by recovery of the endothelial glycocalyx barrier
- (2020) Marta Targosz-Korecka et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Why is hyperglycemia worsening COVID ‐19 and its prognosis?
- (2020) Antonio Ceriello et al. DIABETES OBESITY & METABOLISM
- Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory
- (2020) Antonio Ceriello DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin and COVID‐19: A novel deal of an Old Drug
- (2020) Amr Ahmed EL‐Arabey et al. JOURNAL OF MEDICAL VIROLOGY
- Metformin and COVID-19: From cellular mechanisms to reduced mortality
- (2020) A.J. Scheen DIABETES & METABOLISM
- Metformin, neutrophils and COVID-19 infection
- (2020) Rinkoo Dalan DIABETES RESEARCH AND CLINICAL PRACTICE
- Metformin in COVID-19: A possible role beyond diabetes
- (2020) Swati Sharma et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
- (2020) Bo Wang et al. Journal of Hematology & Oncology
- Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression
- (2020) Raymond Pranata et al. Journal of Stroke & Cerebrovascular Diseases
- ACE2, Metformin, and COVID-19
- (2020) Atul Malhotra et al. iScience
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
- (2020) Yongchao Gao et al. CTS-Clinical and Translational Science
- Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
- (2020) Chia Siang Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19
- (2020) Minako Yamaoka-Tojo Biomedical Journal
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
- (2020) Jean-Daniel Lalau et al. DIABETES & METABOLISM
- Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study
- (2020) Nan Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Treatment response between Asian and non-Asian patients with type 2 diabetes
- (2019) Xiao-Ling Cai et al. CHINESE MEDICAL JOURNAL
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
- (2019) Marc Foretz et al. Nature Reviews Endocrinology
- Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis
- (2019) Jiang Xu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Metformin Might Inhibit Virus through Increasing Insulin Sensitivity
- (2018) Jian-Long Guan et al. CHINESE MEDICAL JOURNAL
- Virus-Induced Interferon-γ Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity
- (2018) Marko Šestan et al. IMMUNITY
- Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter
- (2018) Hiroko Hashimoto et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metformin improves obesity-associated inflammation by altering macrophages polarization
- (2018) Yuanyuan Jing et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metabolic Profiles Associated With Metformin Efficacy in Cancer
- (2018) Sylvia Andrzejewski et al. Frontiers in Endocrinology
- Metformin attenuates renal medullary hypoxia in diabetic nephropathy through inhibition uncoupling protein-2
- (2018) Michael Christensen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data
- (2017) L. Nesti et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
- (2016) Wei Chen et al. Journal of Inflammation-London
- Cellular senescence in renal ageing and disease
- (2016) Ines Sturmlechner et al. Nature Reviews Nephrology
- Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis
- (2016) Md. Mohaimenul Islam et al. NEUROEPIDEMIOLOGY
- T cell metabolic fitness in antitumor immunity
- (2015) Peter J. Siska et al. TRENDS IN IMMUNOLOGY
- Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes
- (2014) Bart B. L. Groen et al. JOURNAL OF APPLIED PHYSIOLOGY
- Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome
- (2013) Neeraj Desai et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice
- (2013) Bart JM Eskens et al. Cardiovascular Diabetology
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
- (2013) Madhusudhanan Sukumar et al. JOURNAL OF CLINICAL INVESTIGATION
- Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage
- (2012) C. Algire et al. Cancer Prevention Research
- Effectiveness of Metformin on Weight Loss in Non-Diabetic Individuals with Obesity
- (2012) C. Seifarth et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Metformin prevents endoplasmic reticulum stress-induced apoptosis through AMPK-PI3K-c-Jun NH2 pathway
- (2011) Tae Woo Jung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway
- (2010) Xinguo Hou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines
- (2008) Ghazal Ansari et al. ADVANCES IN THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started